News

SpermComet® remains the proprietary technology that powers the Exact® range of sperm DNA tests. Examen’s Sperm DNA Fragmentation Tests, powered […]

Understanding the causes of infertility is essential to improving the outcomes of Assisted Reproductive Technology (ART). It was great to

Lockdown and Brexit bring additional challenges but we are open to offer our Exact tests As we once again enter

New study reveals Sperm DNA damage is a key indicator of the likelihood of miscarriage Belfast, UK, 26th October 2020

Eileen Regan joins Examen as Chief Commercial Officer as the company expands to meet the needs of the UK’s top

Examen has received further support from Invest Northern Ireland under the European Union’s Investment for Growth and Jobs Programme. The

There are many unanswered questions when it comes to male fertility research. Of couples seeking IVF treatment, the second most